Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44018126HTLV-1ENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS44014467HTLV-1ENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS44014468HTLV-1ENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS44036476HTLV-1ENSG00000171791.14protein_codingBCL2YesNo596P10415
TCGA Plot Options
Drug Information
GeneBCL2
DrugBank IDDB01367
Drug NameRasagiline
Target IDBE0000246
UniProt IDP10415
Regulation Typeactivator
PubMed IDs12043833; 12057839; 12200198; 14555244; 16148027
CitationsYoudim MB, Weinstock M: Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]. Cell Mol Neurobiol. 2001 Dec;21(6):555-73.@@Akao Y, Maruyama W, Yi H, Shamoto-Nagai M, Youdim MB, Naoi M: An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells. Neurosci Lett. 2002 Jun 28;326(2):105-8.@@Maruyama W, Akao Y, Carrillo MC, Kitani K, Youdium MB, Naoi M: Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes. Neurotoxicol Teratol. 2002 Sep-Oct;24(5):675-82.@@Youdim MB, Amit T, Falach-Yogev M, Bar Am O, Maruyama W, Naoi M: The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline. Biochem Pharmacol. 2003 Oct 15;66(8):1635-41.@@Bar-Am O, Weinreb O, Amit T, Youdim MB: Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine. FASEB J. 2005 Nov;19(13):1899-901. Epub 2005 Sep 7.
GroupsApproved
Direct ClassificationIndanes
SMILESC#CCN[C@@H]1CCC2=CC=CC=C12
Pathways
PharmGKBPA164764584
ChEMBLCHEMBL887